Sensus Healthcare (SRTS) Return on Capital Employed (2018 - 2025)
Sensus Healthcare's (SRTS) quarterly Return on Capital Employed came in at 20.23% in Q4 2025, down 3490.0% year-on-year from 0.6% in Q4 2024, and down 92.8% quarter-over-quarter from 10.49% in Q3 2025.
Sensus Healthcare (SRTS) Return on Capital Employed (2018 - 2025) Analysis & Trends
Sensus Healthcare's Return on Capital Employed history runs 8 years deep, the most recent figure standing at 20.23% for Q4 2025.
- On a quarterly basis, Return on Capital Employed fell 3490.0% year-over-year to 20.23% in Q4 2025; TTM through Dec 2025 was 20.23%, a 3490.0% decrease from a year earlier, with the FY2025 full-year figure at 19.49%, down 3503.0% from the prior year.
- Return on Capital Employed declined to 20.23% in Q4 2025 per SRTS's latest filing, from 10.49% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 32.63% in Q3 2022 and bottomed at 25.31% in Q1 2021.
- The 5-year median for Return on Capital Employed is 7.83% (2024), against an average of 7.32%.
- Across the five-year window, Return on Capital Employed jumped 5372 bps in 2021 and tumbled 3652 bps in 2023, its largest moves.
- Year by year, Return on Capital Employed stood at 17.94% in 2021, then surged by 72 bps to 30.87% in 2022, then plunged by 103 bps to 0.8% in 2023, then jumped by 1931 bps to 14.68% in 2024, then plunged by 238 bps to 20.23% in 2025.
- Per Business Quant, the three latest SRTS Return on Capital Employed figures stand at 20.23% (Q4 2025), 10.49% (Q3 2025), and 2.58% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.23% |
| Sep 30, 2025 | -10.49% |
| Jun 30, 2025 | -2.58% |
| Mar 31, 2025 | 4.69% |
| Dec 31, 2024 | 14.68% |
| Sep 30, 2024 | 22.19% |
| Jun 30, 2024 | 16.12% |
| Mar 31, 2024 | 10.88% |
| Dec 31, 2023 | -0.80% |
| Sep 30, 2023 | -3.88% |
| Jun 30, 2023 | 4.77% |
| Mar 31, 2023 | 16.29% |
| Dec 31, 2022 | 30.87% |
| Sep 30, 2022 | 32.63% |
| Jun 30, 2022 | 31.17% |
| Mar 31, 2022 | 27.92% |
| Dec 31, 2021 | 17.94% |
| Sep 30, 2021 | -4.44% |
| Jun 30, 2021 | -16.06% |
| Mar 31, 2021 | -25.31% |